In partnership with The ALS Association, NEALS offers a variety of educational webinars for the ALS community.
Presented by Drs. Gabrielle Steinhorn and Nicholas J. Maragakis from Johns Hopkins University. Dr. Maragakis reviews the results of the recently completed Trial of Resistance and Endurance Exercise in ALS and Dr. Steinhorn…
Radicava (edaravone) is a drug that was approved by the U.S. Food and Drug Administration (FDA) to treat people with ALS in May of 2017. Dr. Jonathan Glass, Emory University, opens the presentation with a summary of the clinical trial…
In this presentation, Sherry Kolodziejczak, MS, OTR/L, Crestwood Medical Center, reviews the documentation requirements for power wheelchair evaluation. The Medicare Power Wheelchair form is reviewed in a line-by-line basis teaching the…
In this webinar, Jeremy M. Shefner, MD, PhD, Barrow Neurological Institute, reviews the large phase 2 study of CK107 that is now in progress across the US. He discusses the trial design, hopes for the drug, and answers questions from…
Speaker: Shafeeq S. Ladha, M.D., Barrow Neurological InstituteALSA-BIO3 is an observational clinical study funded by ALSA and the Fulton Family Foundation. In this study, biofluids as well as clinical and electrophysiologic measures…
Dr. Sabrina Paganoni, Massachusetts General Hospital, reviews CENTAUR, a new trial for people with ALS. CENTAUR ("Combination of Phenylbutyrate and Tauroursodeoxycholic Acid") is a Phase 2 trial that will test the efficacy and safety of…
Dr. Shafeeq Ladha from Barrow Neurological Institute will review the clinical trial of Actemra in ALS patients and provide a trial update. He will discuss the rationale for using the drug, the role of inflammation in ALS progression and…
On 16 May 2014, a news story appeared on American television and online, highlighting dramatic improvements in a patient with ALS taking a nutritional supplement called lunasin. This webinar will review how ALSUntangled…
Amyotrophic lateral sclerosis (ALS) is thought to be a disease with a genetic predisposition and environmental triggers. Elijah Stommel, MD, PhD (Geisel School of Medicine at Dartmouth) will discuss some potential important…
Speakers: Jeremy Shefner, MD, PhD, Barrow Neurological Institute and Seward Rutkove, MD, Harvard Medical SchoolALS AT HOME is a new kind of research study that follows ALS disease progression and collects data on a number of different…